ALK and non-small cell lung carcinoma: Altogether, these results suggest that while comprehensive ctDNA analysis (i.e., using ΔVAFmean and Δt-MAD) remains superior for tumour monitoring in ALK + NSCLC, the information provided by serum cytokines, particularly of ΔIL-8, is independent and complementary to ctDNA mutational analysis data.